-
Published 8/8/2025
Wood-Trageser MA, Nichols CT, Hutchings DA, Bell D, Wald AI, Smith K, Hong SM, Luchini C, Brosens LAA, Verschuur AVD, Bevere M, Lawlor RT, Scarpa A, Keating S, Tucker J, O'Sullivan RJ, Liu TC, McGrath K, Fasanella K, Brand RE, Lennon AM, Das R, Singh H, Slivka A, Mahmood S, Hosmer AE, Khalid A, Romutis SL, Zureikat AH, Zeh HJ, Hogg ME, Lee KK, Paniccia A, Nunns G, Ongchin M, Park WG, Polanco PM, He J, Simeone DM, Ferrone CR, Hsu D, Zhang J, Gorantla V, Rhee J, Hruban RH, Singhi AH, Singhi SA, Wang CK, Shaker N, Bubar R, Grupillo M, Lai YT, Nikiforova MN, Heaphy CM, Waters KM, Singhi AD. Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis. Mod Pathol. 2025 Oct; 38(10):100863. PMID: 40784487.
-
Published 7/24/2025
Solivio C, Yuan G, Rizzo AJ, Graham MK, Shenker L, Vista W, Gil A, Singh H, Alexander E, Gonzalez-Aguirre A, Latzman J, Petre EN, Yarmohammadi H, Erinjeri JP, Covey A, Chan E, Russell J, Bodei L, Raj N, Reidy-Lagunes D, Heaphy CM, Ziv E. Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization. Neuroendocrinology. 2025; 115(9):730-740. PMID: 40706576.
-
Published 7/19/2025
Arbesfeld-Qiu JM, Cho JW, Nguyen PTT, Lester NA, Su J, Guo JA, Hoffman H, Shiau C, Caldwell N, Muratani S, Galvan M, Proctor JE, Ely Z, Wang S, Ganci M, Dries R, Hong T, Wo J, Boland G, Fernandez-Del Castillo C, Ferrone C, Heaphy CM, Zhang ML, Mino-Kenudson M, Hemberg M, Hwang WL. Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumors. bioRxiv. 2025 Jul 19. PMID: 40791359.
-
Published 4/4/2025
Verschuur AVD, Chen L, Nieveen van Dijkum EJ, Luchini C, Halfdanarson TR, Hong SM, Singhi AD, Brosens LAA, Heaphy CM. Management of patients with small pancreatic neuroendocrine tumors from a biomarker and surgical perspective. Endocr Relat Cancer. 2025 May 01; 32(5). PMID: 40117346.
-
Published 11/9/2024
Heaphy CM, Patel S, Smith K, Wondisford AR, Lynskey ML, O'Sullivan RJ, Fuhrer K, Han X, Seethala RR, Liu TC, Cao D, Ertunc O, Zheng Q, Stojanova M, Zureikat AH, Paniccia A, Lee K, Ongchin MC, Pingpank JF, Zeh HJ, Hogg ME, Geller D, Marsh JW, Brand RE, Chennat JS, Das R, Fasanella KE, Gabbert C, Khalid A, McGrath K, Lennon AM, Sarkaria S, Singh H, Slivka A, Hsu D, Zhang JY, Nacev BA, Nikiforova MN, Wald AI, Vaddi N, De Marzo AM, Singhi AH, Bell PD, Singhi AD. Detection of Alternative Lengthening of Telomeres via Chromogenic In Situ Hybridization for the Prognostication of PanNETs and Other Neoplasms. Mod Pathol. 2025 Mar; 38(3):100651. PMID: 39522643.